World's Best Scientists 2026 revealed!
Lars Klareskog

Lars Klareskog

Award Badge
Immunology
Sweden
2026
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Immunology

D-Index
157
Citations
92617
World Ranking
95
National Ranking
1

Medicine

D-Index
158
Citations
94319
World Ranking
855
National Ranking
19

Lars Klareskog publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lars Klareskog sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 873 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lars Klareskog D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Klareskog sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 157 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Sweden Leader Award
  • 2025 - Research.com Immunology in Sweden Leader Award
  • 2023 - Research.com Medicine in Sweden Leader Award
  • 2022 - Research.com Immunology in Sweden Leader Award

Overview

Lars Klareskog is affiliated with the Karolinska Institute in Sweden and has a significant body of research primarily in the field of Medicine with a focus on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Genetics, and Pathology and Forensic Medicine. Their work addresses a range of complex issues in autoimmune and inflammatory diseases.

The scientist's research covers several main topics, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research
  • T-cell and B-cell Immunology
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research

Among the recent publications authored or co-authored by Klareskog are:

  • "Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets," 2023, Nature Immunology
  • "Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis," 2022, Nature Genetics
  • "FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease," 2020, Nature
  • "Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study," 2021, Annals of the Rheumatic Diseases
  • "The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis," 2020, Journal of Internal Medicine

Klareskog frequently collaborates with other researchers, including Lars Alfredsson, Leonid Padyukov, Vivianne Malmström, Saedís Saevarsdóttir, and Johan Askling. These collaborations have contributed to a significant output in well-regarded venues.

The most common publication venues for Klareskog include:

  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Lara D. Veeken
  • Arthritis Research & Therapy

Lars Klareskog's research contributions span genetics, immunology, and clinical studies related to autoimmune diseases, with an emphasis on rheumatoid arthritis and related inflammatory disorders. This multidisciplinary approach involves both genetic analyses and studies of environmental interactions, contributing to ongoing understanding of disease mechanisms and potential therapeutic targets.

Best Publications

  • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

    Lars Klareskog;Désirée van der Heijde;Julien P de Jager;Andrew Gough

  • Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Yukinori Okada;Yukinori Okada;Di Wu;Di Wu;Di Wu;Gosia Trynka;Gosia Trynka;Towfique Raj;Towfique Raj

  • Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

    Daniel Tracey;Lars Klareskog;Eric H. Sasso;Jochen G. Salfeld

  • A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.

    Lars Klareskog;Patrik Stolt;Karin Lundberg;Henrik Källberg

  • Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

    Eli A Stahl;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Gang Xie

  • Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Phil H. Lee;Verneri Anttila;Hyejung Won;Yen-Chen A. Feng

  • STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Elaine F. Remmers;Robert M. Plenge;Annette T. Lee;Robert R. Graham;Robert R. Graham

  • EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

    Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu

  • Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa

    Hunna J. Watson;Hunna J. Watson;Hunna J. Watson;Zeynep Yilmaz;Laura M. Thornton;Christopher Hübel;Christopher Hübel

  • Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis

    Soumya Raychaudhuri;Cynthia Sandor;Eli A. Stahl;Eli A. Stahl;Jan Freudenberg

  • Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis

    Yun Liu;Martin J Aryee;Leonid Padyukov;M Daniele Fallin;M Daniele Fallin

  • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

    Eva Baecklund;Anastasia Iliadou;Johan Askling;Anders Ekbom;Anders Ekbom

  • TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study

    Robert M. Plenge;Mark Seielstad;Leonid Padyukov;Annette T. Lee

  • A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

    Leonid Padyukov;Camilla Silva;Patrik Stolt;Lars Alfredsson

  • Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases

    P Stolt;C Bengtsson;B Nordmark;S Lindblad

  • Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

    Ulrike Harre;Dan Georgess;Holger Bang;Aline Bozec

  • High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis

    Steve Eyre;John Bowes;John Bowes;Dorothée Diogo;Dorothée Diogo;Annette Lee

  • Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

    Désirée van der Heijde;Lars Klareskog;Vicente Rodriguez-Valverde;Catalin Codreanu

  • Incidence of Cancer Among Patients With Rheumatoid Arthritis

    Gloria Gridley;Joseph K. McLaughlin;Anders Ekbom;Lars Klareskog

  • Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

    Edward C. Keystone;Mark C. Genovese;Lars Klareskog;Elizabeth C. Hsia

  • Rheumatoid arthritis

    Unknown

Frequent Co-Authors

Lars Alfredsson
Lars Alfredsson Karolinska Institute
Leonid Padyukov
Leonid Padyukov Karolinska Institute
Rikard Holmdahl
Rikard Holmdahl Karolinska Institute
Anca I. Catrina
Anca I. Catrina Karolinska University Hospital
Vivianne Malmström
Vivianne Malmström Karolinska University Hospital
Johan Rönnelid
Johan Rönnelid Uppsala University
Robert M. Plenge
Robert M. Plenge Bristol Myers Squibb
Peter K. Gregersen
Peter K. Gregersen Feinstein Institute for Medical Research
Johan Askling
Johan Askling Karolinska Institute
Jane Worthington
Jane Worthington University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare career options can provide valuable opportunities. Many professionals transition into fields like nursing, where a strong foundation in biology and patient care is essential. Accelerated nursing pathways allow students to fast-track their education and enter the workforce sooner, making programs like nurse practitioner accelerated program especially appealing for those seeking advanced clinical roles.

Individuals without a nursing background can still pursue nursing degrees through accessible options such as online absn programs for non nurses. These programs are designed to equip students with essential skills quickly, aiding in their transition to nursing careers.

Finding suitable programs nearby can be crucial, especially for hands-on components. Resources listing accelerated nursing programs near me help prospective students identify convenient educational paths that fit their schedules.

Entry into the nursing profession can also begin with programs like Licensed Practical Nurse training. Researching the best easiest lpn programs to get into helps candidates select accessible programs suited to their needs, supporting a wide range of healthcare career pathways related to immunology research and practice.

Best Scientists Citing Lars Klareskog

Trending Scientists

Recently Published Articles